89bio, Inc.
ETNB
$9.03
-$0.39-4.14%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 3.53% | 7.60% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 52.58% | -37.78% | |||
Operating Income | -52.58% | 37.78% | |||
Income Before Tax | -55.68% | 39.76% | |||
Income Tax Expenses | 449.64% | -46.69% | |||
Earnings from Continuing Operations | -56.44% | 39.78% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -56.44% | 39.78% | |||
EBIT | -52.58% | 37.78% | |||
EBITDA | -52.59% | 37.79% | |||
EPS Basic | -45.03% | 52.29% | |||
Normalized Basic EPS | -40.56% | 51.85% | |||
EPS Diluted | -45.03% | 52.29% | |||
Normalized Diluted EPS | -40.56% | 51.85% | |||
Average Basic Shares Outstanding | 7.87% | 26.22% | |||
Average Diluted Shares Outstanding | 7.87% | 26.22% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |